Følg
Mary-Louise Rogers
Mary-Louise Rogers
Verifisert e-postadresse på flinders.edu.au - Startside
Tittel
Sitert av
Sitert av
År
Targeted drug delivery using genetically engineered diatom biosilica
B Delalat, VC Sheppard, SR Ghaemi, S Rao, CA Prestidge, G McPhee, ...
Nature Communications 6 (8791), doi: 10.1038/ncomms9791, 2015
3142015
Isolation and enrichment of embryonic mouse motoneurons from the lumbar spinal cord of individual mouse embryos
S Wiese, T Herrmann, C Drepper, S Jablonka, N Funk, A Klausmeyer, ...
Nature protocols 5 (1), 31-38, 2010
1472010
Drug Delivery: Antibody‐Functionalized Porous Silicon Nanoparticles for Vectorization of Hydrophobic Drugs (Adv. Healthcare Mater. 5/2013)
E Secret, K Smith, V Dubljevic, E Moore, P Macardle, B Delalat, ...
Advanced Healthcare Materials 2 (5), 626-626, 2013
137*2013
Urinary p75ECD A prognostic, disease progression, and pharmacodynamic biomarker in ALS
SR Shepheard, J Wuu, M Cardoso, L Wiklendt, PG Dinning, T Chataway, ...
Neurology 88 (12), 1137-1143, 2017
1172017
Porous Silicon Nanodiscs for Targeted Drug Delivery
H Alhmoud, B Delalat, R Elnathan, A Cifuentes-Rius, A Chaix, ML Rogers, ...
Advanced Functional Materials 25 (7), 1137-1145, 2015
1022015
Milk-derived growth factors as serum supplements for the growth of fibroblast and epithelial cells
DA Belford, ML Rogers, GO Regester, GL Francis, GW Smithers, IJ Liepe, ...
In Vitro Cellular & Developmental Biology-Animal 31, 752-760, 1995
911995
Non-viral gene therapy for neurological diseases, with an emphasis on targeted gene delivery
ML Rogers, RA Rush
Journal of controlled release 157 (2), 183-189, 2012
902012
Transforming growth factor β in bovine milk: concentration, stability and molecular mass forms
ML Rogers, C Goddard, GO Regester, FJ Ballard, DA Belford
Journal of Endocrinology 151 (1), 77-86, 1996
891996
Safety and tolerability of Triumeq in amyotrophic lateral sclerosis: the Lighthouse trial
Amyotroph Lateral Scler Frontotemporal Degener 63, 1–10., 2019
87*2019
Characterization and use of the NSC‐34 cell line for study of neurotrophin receptor trafficking
D Matusica, MP Fenech, ML Rogers, RA Rush
Journal of neuroscience research 86 (3), 553-565, 2008
772008
The extracellular domain of neurotrophin receptor p75 as a candidate biomarker for amyotrophic lateral sclerosis
SR Shepheard, T Chataway, DW Schultz, RA Rush, ML Rogers
PLoS One 9 (1), e87398, 2014
762014
ProNGF mediates death of Natural Killer cells through activation of the p75NTR–sortilin complex
ML Rogers, S Bailey, D Matusica, I Nicholson, H Muyderman, ...
Journal of Neuroimmunology 226 (1-2), 93-103, 2010
612010
Platelet-derived growth factor, insulin-like growth factors, fibroblast growth factors and transforming growth factor β do not account for the cell growth activity present in …
DA Belford, ML Rogers, GL Francis, C Payne, FJ Ballard, C Goddard
Journal of endocrinology 154 (1), 45-55, 1997
471997
Inhibition of HERV-K (HML-2) in amyotrophic lateral sclerosis patients on antiretroviral therapy
M Garcia-Montojo, S Fathi, G Norato, BR Smith, DB Rowe, MC Kiernan, ...
Journal of the neurological sciences 423, 117358, 2021
442021
Identification of fibroblast growth factors in bovine cheese whey
ML Rogers, DA Belford, GL Francis, FJ Ballard
Journal of Dairy Research 62 (3), 501-507, 1995
431995
CD 271 (P75 neurotrophin receptor)
M Rogers, A Beare, H Zola, RA Rush
Journal of Biological Regulators and Homeostatic Agents 22 (1), 1-6, 2008
362008
Functional monoclonal antibodies to p75 neurotrophin receptor raised in knockout mice
ML Rogers, I Atmosukarto, DA Berhanu, D Matusica, P Macardle, ...
Journal of neuroscience methods 158 (1), 109-120, 2006
362006
Choroid plexus transplants in the treatment of brain diseases
SJM Skinner, MS Geaney, R Rush, ML Rogers, DF Emerich, CG Thanos, ...
Xenotransplantation 13 (4), 284-288, 2006
342006
Urinary extracellular domain of neurotrophin receptor p75 as a biomarker for amyotrophic lateral sclerosis in a Chinese cohort
R Jia, S Shepheard, J Jin, F Hu, X Zhao, L Xue, L Xiang, H Qi, Q Qu, ...
Scientific Reports 7 (1), 5127, 2017
332017
Removal of p75 Neurotrophin receptor expression from cholinergic basal forebrain neurons reduces amyloid-β plaque deposition and cognitive impairment in aged APP/PS1 mice
L Qian, MR Milne, S Shepheard, ML Rogers, R Medeiros, EJ Coulson
Molecular neurobiology 56, 4639-4652, 2019
312019
Systemet kan ikke utføre handlingen. Prøv på nytt senere.
Artikler 1–20